CN Patent

CN100508981C — 哌嗪衍生物药物组合物

Assigned to UCB Farchim SA · Expires 2009-07-08 · 17y expired

What this patent protects

本发明涉及包含属于取代的二苯甲基哌嗪家族的活性物质和减量防腐剂的液体组合物。

USPTO Abstract

本发明涉及包含属于取代的二苯甲基哌嗪家族的活性物质和减量防腐剂的液体组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN100508981C
Jurisdiction
CN
Classification
—
Expires
2009-07-08
Drug substance claim
No
Drug product claim
No
Assignee
UCB Farchim SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.